rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joseph Edelman

Director

Company insider

Files Form 4 as: Director, Immatics; Director and 10% owner, LeonaBio; Director, Kardigan; Director and 10% owner, Solid Biosciences; 10% owner, Lyra Therapeutics; 10% owner, Adagio Medical Holdings; Director and 10% owner, MeiraGTx Holdings; 10% owner, Aldeyra Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
188
Buys
82
Sells
19
Bought
$310.2M
Sold
$23.9M
Companies
40
Companies where not an officer
40
First trade
29 Jun 2006
Last trade
26 Aug 2026
Last filed
27 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMTX ImmaticsDirector · Biotechnology · last 26 Aug 20261 buy · 0 sells
LONA LeonaBioDirector, 10% owner · Biotechnology · last 23 Jun 20267 buys · 0 sells
KARD KardiganDirector · Biotechnology · last 17 Jun 20260 buys · 0 sells
SLDB Solid BiosciencesDirector, 10% owner · Biotechnology · last 10 Jun 20262 buys · 0 sells
Lyra Therapeutics10% owner · last 10 Nov 20250 buys · 3 sells
ADGM Adagio Medical Holdings10% owner · Medical Devices · last 20 Oct 20250 buys · 0 sells
MGTX MeiraGTx HoldingsDirector, 10% owner · Biotechnology · last 12 Jun 20252 buys · 0 sells
ALDX Aldeyra Therapeutics10% owner · Biotechnology · last 5 Apr 20246 buys · 0 sells
VRCA Verrica Pharmaceuticals10% owner · Biotechnology · last 29 Dec 20233 buys · 0 sells
CARGO TherapeuticsOther · last 14 Nov 20231 buy · 0 sells
Cerevel Therapeutics HoldingsDirector · last 16 Oct 20232 buys · 0 sells
Soleno Therapeutics10% owner · last 26 May 20233 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
301Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Aug 2026filed 27 Aug 2026IMTX ImmaticsBiotechnologySEC FORM 4 Bought$7.5M863,060 at $8.69filing
23 Jun 2026filed 9 Jul 2026LONA LeonaBiooption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
23 Jun 2026filed 24 Jun 2026LONA LeonaBiooption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
23 Jun 2026filed 24 Jun 2026LONA LeonaBiooption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
17 Jun 2026filed 13 Jul 2026KARD KardiganBiotechnologySEC FORM 4 Code A—20,706 at $0.00filing
10 Jun 2026filed 11 Jun 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing
9 Apr 2026filed 13 Apr 2026LONA LeonaBiooption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
9 Apr 2026filed 13 Apr 2026LONA LeonaBiooption or derivative · BiotechnologySEC FORM 4 Code A—28,000 at $0.00filing
10 Nov 2025filed 10 Nov 2025Lyra TherapeuticsSEC FORM 4 Sold$76K16,633 at $4.54filing
10 Nov 2025filed 10 Nov 2025Lyra TherapeuticsSEC FORM 4 Sold$8,4851,869 at $4.54filing
7 Nov 2025filed 10 Nov 2025Lyra TherapeuticsSEC FORM 4 Sold$84K17,746 at $4.75filing
7 Nov 2025filed 10 Nov 2025Lyra TherapeuticsSEC FORM 4 Sold$9,4671,993 at $4.75filing
6 Nov 2025filed 10 Nov 2025Lyra TherapeuticsSEC FORM 4 Sold$150K28,902 at $5.18filing
6 Nov 2025filed 10 Nov 2025Lyra TherapeuticsSEC FORM 4 Sold$17K3,247 at $5.18filing
20 Oct 2025filed 22 Oct 2025ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code P$242K1,344,999 at $0.18filing
20 Oct 2025filed 22 Oct 2025ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code P$242K1,344,999 at $0.18filing
20 Oct 2025filed 22 Oct 2025ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code P$242K1,344,999 at $0.18filing
20 Oct 2025filed 22 Oct 2025ADGM Adagio Medical Holdingsoption or derivative · Medical DevicesSEC FORM 4 Code P$3.5M2,190,496 at $1.60filing
12 Jun 2025filed 16 Jun 2025MGTX MeiraGTx Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
12 Jun 2025filed 13 Jun 2025SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing

News

Immatics (NASDAQ:IMTX) & Anixa Biosciences (NASDAQ:ANIX) Financial ComparisonIMTX · dailypolitical.com · 16 Oct 2026Exicure (NASDAQ:XCUR) & Immatics (NASDAQ:IMTX) Head-To-Head AnalysisIMTX · tickerreport.com · 11 Oct 2026

0 headlines in the last 90 days name Joseph Edelman; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care45
Not placed56

Buys in green, sells in red, by the company’s sector.

Related people

Ian F. SmithDirector · Director at Solid Biosciences, filing Form 4 there in the last year
Kristin Marie K. ReinkeDirector · Director at Kardigan, filing Form 4 there in the last year
PERCEPTIVE ADVISORS LLCDirector · Director at Immatics, filing Form 4 there in the last year
James Nelson PepinGen Counsel and Corp Secretary · Gen Counsel and Corp Secretary at Immatics, filing Form 4 there in the last year
Grant PickeringChief Executive Officer · Director at LeonaBio, filing Form 4 there in the last year
Stuart NaylorChief Sci Ofcr, Ophthalmology · Also traded MGTX in the last 90 days
Alexandria ForbesPresident & CEO · Also traded MGTX in the last 90 days
John J. KirbyInterim CFO · Also traded VRCA in the last 90 days